海圣医疗
(920166)
| 流通市值：4.43亿 | | | 总市值：14.05亿 |
| 流通股本：2376.47万 | | | 总股本：7529.41万 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 260,348,848.11 | 162,345,228.59 | 73,495,192.83 | 345,286,102.13 |
| 营业总成本 | 203,001,315.45 | 128,373,015.8 | 59,956,210.72 | 254,337,555.78 |
| 其他经营收益 | | | | |
| 营业利润 | 59,496,141.61 | 36,099,943.59 | 14,940,972.01 | 97,919,094.93 |
| 利润总额 | 59,300,900.49 | 35,904,702.47 | 14,750,806.84 | 97,744,458.73 |
| 净利润 | 51,710,830.94 | 30,662,409.68 | 12,101,873.65 | 85,815,891.13 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 51,710,830.94 | 30,662,409.68 | 12,101,873.65 | 85,815,891.13 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 311,056,267.82 | 288,044,781.57 | 294,787,347.82 | 209,176,955.3 |
| 非流动资产: | | | | |
| 非流动资产合计 | 418,306,211.03 | 415,336,775.43 | 410,692,342.3 | 387,333,556.38 |
| 资产总计 | 729,362,478.85 | 703,381,557 | 705,479,690.12 | 596,510,511.68 |
| 流动负债: | | | | |
| 流动负债合计 | 64,479,235.73 | 59,944,507.03 | 61,498,930.99 | 78,401,214.55 |
| 非流动负债: | | | | |
| 非流动负债合计 | 1,471,328.51 | 1,269,494.12 | 20,569,676.81 | 20,434,234.8 |
| 负债合计 | 65,950,564.24 | 61,214,001.15 | 82,068,607.8 | 98,835,449.35 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 663,411,914.61 | 642,167,555.85 | 623,411,082.32 | 497,675,062.33 |
| 股东权益合计 | 663,411,914.61 | 642,167,555.85 | 623,411,082.32 | 497,675,062.33 |
| 负债和股东权益合计 | 729,362,478.85 | 703,381,557 | 705,479,690.12 | 596,510,511.68 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 305,232,817.03 | 196,320,288.01 | 109,404,785.68 | 380,952,005.56 |
| 经营活动现金流出小计 | 261,859,153.91 | 186,641,844.74 | 95,670,380.3 | 262,866,934.42 |
| 经营活动产生的现金流量净额 | 43,373,663.12 | 9,678,443.27 | 13,734,405.38 | 118,085,071.14 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 183,382,289.66 | 123,243,966.38 | 39,041,798.63 | 30,138,613.82 |
| 投资活动现金流出小计 | 292,600,273.8 | 213,721,590.37 | 70,807,914.01 | 107,433,829.89 |
| 投资活动产生的现金流量净额 | -109,217,984.14 | -90,477,623.99 | -31,766,115.38 | -77,295,216.07 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 130,557,651.52 | 130,557,651.52 | 130,557,651.52 | - |
| 筹资活动现金流出小计 | 15,814,102.92 | 15,403,333.4 | 14,127,978.75 | 3,815,616 |
| 筹资活动产生的现金流量净额 | 114,743,548.6 | 115,154,318.12 | 116,429,672.77 | -3,815,616 |
| 汇率变动对现金及现金等价物的影响 | -1,423,610.28 | -1,020,985.29 | -504,352.4 | -394,173.78 |
| 现金及现金等价物净增加额 | 47,475,617.3 | 33,334,152.11 | 97,893,610.37 | 36,580,065.29 |
| 期末现金及现金等价物余额 | 130,788,279.34 | 116,646,814.15 | 181,206,272.41 | 83,312,662.04 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | 33,334,152.11 | - | 36,580,065.29 |